RecruitingNot ApplicableNCT06230380

Autofluorescence in Surgery for Primary Hyperparathyroidism

Use of Intraoperative Autofluorescence Imaging in Surgery for Primary Hyperparathyroidism - a Randomized Controlled Trial.


Sponsor

Aarhus University Hospital

Enrollment

100 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age\>18 years and able to give informed consent.
  • A diagnosis of PHPT.
  • Planned exploratory PTX with ioPTH measurement.

Exclusion Criteria6

  • Concordant high-confidence imaging; planned focused/selective PTX
  • Previous thyroid or parathyroid surgery.
  • Planned simultaneous thyroid surgery.
  • MEN, lithium induced hyperparathyroidism.
  • eGFR \< 30.
  • Kidney transplant.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgery with autofluorescence

In the experimental group, the surgeon will use the EleVision IR camera system (Medtronic, USA) to visualize PTGs during surgery. The surgical field will be visualized with AF as a minimum of two times during surgery on each side of the neck: First upon exposing the undersurface of the thyroid gland, and secondly before removal of a pathological PTG. Also, removed PTGs will be examined ex vivo to document AF pattern.


Locations(1)

Aarhus University Hospital

Aarhus, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06230380


Related Trials